A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model
Thom, George, Tian, Mei-Mei, Hatcher, Jon P, Rodrigo, Natalia, Burrell, Matthew, Gurrell, Ian, Vitalis, Timothy Z, Abraham, Thomas, Jefferies, Wilfred A, Webster, Carl I, Gabathuler, ReinhardLanguage:
english
Journal:
Journal of Cerebral Blood Flow & Metabolism
DOI:
10.1177/0271678X18772998
Date:
May, 2018
File:
PDF, 1.24 MB
english, 2018